Posters
ESMO 2023
- Chemotherapy sensitivity score based on ex vivo 3D tumor testing to predict clinical response for ovarian cancer patients
- EVITA trial for ex vivo drug sensitivity testing in urothelial cancer
AACR-NCI-EORTC 2023
ASCO 2023
AACR 2023
Brochures
- Better informed treatment decisions through predictive ex vivo 3D tumor testing
- Accelerate clinical development by early identification of responsive patients in clinical trials